<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0190">
 <label>38</label>
 <element-citation publication-type="journal" id="sbref0190">
  <person-group person-group-type="author">
   <name>
    <surname>Esteva</surname>
    <given-names>F.J.</given-names>
   </name>
   <name>
    <surname>Glaspy</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Baidas</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Laufman</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Hutchins</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Dickler</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Tripathy</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Cohen</surname>
    <given-names>R.</given-names>
   </name>
  </person-group>
  <article-title>Multicenter phase II study of oral bexarotene for patients with metastatic breast cancer</article-title>
  <source>J. Clin. Oncol.</source>
  <volume>21</volume>
  <year>2003</year>
  <fpage>999</fpage>
  <lpage>1006</lpage>
  <pub-id pub-id-type="pmid">12637463</pub-id>
 </element-citation>
</ref>
